International [Chinese COVID Vaccines News] After Sowing Propaganda Against mRNA Tech, China Realize They Needs It

They are urging Indonesia to lock it down now that shit hits the fan (again), with over 10,000 new cases a day. I can only imagine what Sinovac's efficacy rate is against the Delta variants consider that it's barely 50% against the original.

The good news is, the infections are mild and don't require hospitalization. The bad news is, the infected are asymptomatic carriers.

Sinovac: Hundreds of vaccinated Indonesian health workers get Covid-19, dozens in hospital
Story by Reuters | Fri June 18, 2021





https://www.cnn.com/2021/06/18/asia/vaccinated-indonesian-doctors-covid-19-intl-hnk/index.html


Shit....its already in Indonesia Philippines Big Sister accros the pond.


I guess I better start doing my errans since its a matter of time before cases here spike
 
Indeed, "some protection" is better than "no protection".

Now that "a lot of protection" is becoming available to the rest of the world, it's only natural for those who previously had no choice but to opted for "some protection" to make the upgrade.

A cherry-picked clinical trial consists mostly of young men in their 30s is freakin' bullshit though, and the peer-review said just as much about the result now that the highly-questionable details are finally published.
Some might be worse than none. If it prevents you from receiving an effective vaccine for a while, it might be worse than waiting
 
Doubts growing in Latin America about the effectiveness of Chinese COVID vaccines
by Silvina Premat | 06/18/2021​

About 45 per cent of Chileans have been vaccinated, especially with Sinovac, but infections are at their highest since the outbreak of the pandemic. Of the 70 million doses administered in Brazil, 55 per cent are Chinese; yet the number of cases continues to rise. Peru is facing the same issue with Sinopharm. For CADAL researchers, suspicions about Chinese drugs are legitimate.

The number of people vaccinated against COVID-19 in Latin America is increasing at almost the same rate as the number of people infected. The case of Chile – the first country in the region to immunise 45 per cent of its population – is raising suspicions and questions about the effectiveness of Chinese vaccines in a continent where the pandemic has already claimed more than a million lives.

Chile began vaccinating on 3 February this year, relying mostly on CoronaVac, a vaccine made by Sinovac Biotech Ltd, a Chinese pharmaceutical company. However, nationwide infections and intensive care bed occupancy are currently at their highest level since the start of the pandemic.

Faced with doubts about the vaccine’s effectiveness, Chilean authorities released the results of a study that recorded the behaviour of 10.5 million people up to 14 days after receiving the second dose.

According to the study, CoronoVac’s effectiveness in preventing symptomatic COVID-19 is 67 per cent; 85 per cent in cases that required hospitalisation, 89 per cent in cases that needed intensive care (ICU), and 80 per cent of cases prevented death. However, the effectiveness in preventing contagion is 54 per cent. Meanwhile, with one dose the efficacy is 16 per cent for symptomatic COVID-19, 35 per cent with hospitalisation and 40 per cent in death prevention.

“We don't know if [the CoronaVac vaccine] protects against transmission,” says their latest report (11 June) by ICOVID Chile, an initiative of the Universidad de Chile, the Pontificia Universidad Católica de Chile and the Universidad de Concepción, which analyses and reports on the COVID-19 situation in that country based on official data.

ICOVID Chile researchers warn that the effectiveness of the Sinovac vaccine against variants of the coronavirus reported in more than half of the latest cases in people under 50 years of age is unknown.

CoronaVac is also controversial in Brazil. The country of 200 million inhabitants has lost nearly half a million people to COVID-19. About 55 per cent of the 70 million doses administered so far come from the Sinovac vaccine whose effectiveness was criticised months ago by some Brazilian scientists.

However, the Brazilian Health Regulatory Agency (Anvisa) authorised its use, which found it effective in 50 per cent of overall cases and 100 per cent in moderate to severe cases of COVID-19. Still, President Jair Bolsonaro decided against it and on June 16 announced the purchase of 200 million doses of the American Pfizer.

“The CoronaVac can be stored, it appears, for six months. Some people who received it have not developed antibodies. This vaccine has not been scientifically verified,” said Bolsonaro, who is facing serious complaints about his government's handling of the pandemic.

The situation is also particularly serious in Peru where a political crisis has worsened the health situation. In one year the country has had two presidents and four health ministers. Out of a population of 32 million, Peru has reported more than 189,000 deaths related to COVID-19.

The vaccine from China’s Sinopharm state laboratory accounts for about 35 per cent of those administered so far (about eight million) in a slow and uneven campaign. Some of Peru’s Amazonian and mountainous regions are not easily accessible and require special logistics to be reached. In total, 5 per cent of the Peruvian population has received two doses and 10 per cent one.

In addition to the vaccines from Sinopharm and Sinovac, several Latin American countries bought a vaccine from CanSino Biologics, a Chinese private laboratory, whose effectiveness is said to be 65 per cent effective in preventing symptomatic cases with a 90 per cent success rate against severe disease.

“Politically, China’s official discourse dismisses legitimate scientific suspicions aroused by its vaccines as an attempt at Western politicisation,” say Juan Pablo Cardenal and Alfonso Cañal, researchers with CADAL, the Centro para la Apertura y el Desarrollo de América Latina (Centre for Opening and Development in Latin America). However, “The evidence that suspicions about Chinese vaccines are not a Western bias is the fact that the Russian vaccine, evaluated and approved like the others, has not been criticised.”

http://www.asianews.it/news-en/Doub...ess-of-Chinese-anti-COVID-vaccines-53452.html
 
Last edited:
South Africa approves China's Sinovac COVID-19 vaccine - health ministry
By Tim Cocks | July 3, 2021

FUBFS3CGWNJBXA4VEI7ZL2LUTM.jpg

JOHANNESBURG, July 3 (Reuters) - South Africa has approved China's Sinovac vaccine against COVID-19, the acting health minister said on Saturday, as the country faces a crippling third wave of infections that has paralysed hospitals and brought its death toll to 60,000.

"I would like to express gratitude to our regulatory authority for their sense of urgency, which included reducing turnaround time to process applications for registration of ... (the) COVID-19 vaccine," Mamoloko Kubayi said in a statement.

The surge in infections in Africa's most industrialised nation has overwhelmed hospitals, especially in the main city of Johannesburg, and left overworked healthcare personnel struggling to find enough beds for critically ill patients.

Just over 5% of South Africans have been vaccinated -- or 3.3 million people out of a population of just less than 60 million. It has recorded 2 million cases so far, although low testing rates in rural areas mean the real figure is probably higher, health experts say.


After initial doubts owing to a lack of transparency in clinical trial data, Sinovac Biotech's (SVA.O) COVID-19 vaccine is emerging as a powerful tool against the virus. Data from Uruguay released last month showed it was over 90% effective in reducing both intensive care admissions and deaths.

South Africa's low vaccination rate is due to a combination factors including bad luck - the government had to destroy 2 million contaminated Johnson & Johnson vaccines - slow bureaucracy, and richer countries immunising their own citizens first while the developing world waits for its doses.

President Cyril Ramaphosa has appealed to Western drug companies and their allied governments to temporarily waive vaccine patents so other countries can manufacture them -- without success.

Opposition parties have heaped pressure on Ramaphosa to come up with another solution to the vaccine shortage.


The Marxist opposition Economic Freedom Fighters (EFF) last month defied COVID-19 regulations to organise a march in the capital Pretoria, calling for the government to seek vaccines from Russia and China, not just the West.

The EFF on Saturday said the approval of the Sinovac vaccine was "long overdue."

China, where the coronavirus first surfaced in the central city of Wuhan in late 2019, has supplied more than 480 million vaccine doses to other nations.

A statement from the Chinese embassy in South Africa said 2.5 million vaccines had been approved for delivery.

https://www.reuters.com/business/he...id-19-vaccine-domestic-use-health-2021-07-03/
 
Last edited:
It's a weird time. Between the covi protest thread, the thread on Russia's vaccine issues, China's questionable efficacy, you really have to wonder how long we're going to be dealing with this from a health perspective. A lot of developing nations seem to be getting their vaccines from Russia and China and that's going to hamper their recovery.
 
Singapore to exclude Sinovac shots from COVID-19 vaccination tally
By Aradhana Aravindan, Chen Lin | July 7, 2021

AY5IZQ2PEJITJKWL3PN746YY4U.jpg

SINGAPORE, July 7 (Reuters) - People who received Sinovac Biotech (SVA.O) shots are excluded from Singapore's count of total vaccinations against COVID-19, officials in the city state said, citing inadequate efficacy data for the Chinese-made vaccine, especially against the contagious Delta variant.

"We don't really have a medical or scientific basis or have the data now to establish how effective Sinovac is in terms of infection and severe illnesses on Delta," health minister Ong Ye Kung said during a media briefing on Wednesday.

The Delta variant has become the most prevalent strain of COVID-19 in Singapore since a cluster of infections was identified at the airport in May. The government subsequently moved back to stricter curbs on social gatherings and public activities, though it has begun relaxing some of those restrictions.

Only people who participated in the national immunisation programme, which currently uses the Moderna and Pfizer-BioNTech/Cominarty (PFE.N), shots, are counted in the tally for vaccinations.

More than 3.7 million people have received at least one dose of the Pfizer or Moderna vaccines, covering about 65% of the population, and nearly 2.2 million have completed the two-dose regimen.

Singapore has set a target for two-thirds of its people to be fully vaccinated by around Aug. 9.

Following an emergency use approval by the World Health Organization (WHO), Singapore began allowing designated private clinics to offer the Sinovac shot, CoronaVac, from mid-June. Singapore had a stock of 200,000 CoronaVac doses which the clinics could draw on. read more

As of July 3, just over 17,000 people had received one dose of CoronaVac, and authorities say that demand for the vaccine appeared to taper off after an initial rush. read more

Last month, Kenneth Mak, Singapore's director of medical services, said evidence from other countries showed people who had taken CoronaVac were still getting infected, posing a significant risk.

And Singapore has said that people vaccinated with CoronaVac would still need to be tested for COVID-19 before attending certain events or entering some venues, unlike people vaccinated under the national programme.

Singapore has reported 62,652 infections since the pandemic first erupted last year, with most found in foreign worker domitories. But there were only five new locally-acquired cases reported on Wednesday. COVID-19 related deaths stood at 36, one of the lowest rates in the world.

https://www.reuters.com/world/asia-...-shots-covid-19-vaccination-tally-2021-07-07/
 
Last edited:
Indonesia, Thailand mull booster shots for Sinovac
Thu, July 8, 2021



Indonesia and Thailand are considering booster shots for medical workers immunized with the vaccine made by China's Sinovac.

It comes as concerns grow about Chinese vaccines and their effectiveness against new and more transmissible variants.

In Thailand, a leaked health ministry memo showed a comment warning not to give Pfizer booster shots to medical workers.

The quote was made by an unnamed official, who said that such a move could undermine confidence in the effectiveness of Sinovac.

"This is in a meeting which involves various medical professors. They are not civilian staff. Each of them sacrificed their time and were just sharing their views and the minutes of the meeting were recorded. But this doesn't mean the views would turn into action, there are many procedures after that."

Some data has shown Sinovac's vaccine is effective against hospitalization and severe COVID-19 cases.

But there is no detailed data yet on its effectiveness against the highly transmissible Delta variant.

China said this week its vaccines are safe and useful.

That hasn't stopped Singapore from excluding people who received Sinovac shots from its count of total vaccinations due to a lack of data, especially against the Delta variant.

Turkey and the UAE have also started giving booster shots to those inoculated with Chinese vaccines.

The issue is a major challenge for Southeast Asian countries which have relied heavily on China's vaccines due to tight supplies of Western products.

https://news.yahoo.com/indonesia-thailand-mull-sinovac-booster-144135007.html
 
Last edited:
To be fair, only 1 out of 618 infected doctors and nurses actually died so far, but Thailand isn't sitting around waiting for their healthcare workers to drops en masse like Indonesia.​

Hundreds of Thai medical workers inoculated with Sinovac are infected as cases spike in Southeast Asia

By Bryan Pietsch | July 12, 202



More than 600 Thai medical workers who were fully inoculated with the Sinovac vaccine were infected by the coronavirus, which is now raging through Southeast Asia.

The 618 cases were among the 677,348 medical staff who had received two doses of the Chinese-developed coronavirus vaccine between April to July, government data show. Among those infected are a nurse who died and a health-care worker in critical condition.

A Thai health official said Sunday that an expert panel has recommended administering a third dose to at-risk medical workers, adding that the booster shot would be either one from Oxford-AstraZeneca or a messenger RNA vaccine made by either Pfizer-BioNTech or Moderna. The country is set to receive 1.5 million doses of the Pfizer-BioNTech vaccine from the United States this month.

The number of coronavirus cases in Southeast Asia has been relatively low until this year. But many countries in the region are now facing the highly contagious delta variant with low vaccination rates: Only about 5 percent of people in Thailand and Indonesia are fully vaccinated.

The region’s vaccination shortage has been plugged in part by Chinese-made shots, but health experts, including some in China, have raised concerns about the Sinovac vaccine’s efficacy against the delta variant.

In Indonesia, at least 131 health-care workers, many of whom were inoculated with the Sinovac coronavirus vaccine, have died since June.

Thailand has recorded more than 345,000 coronavirus cases and 2,791 deaths. Last week, the Southeast Asian kingdom announced new curbs in Bangkok, the capital, and nine provinces in an attempt to slow transmission of the virus. The tightened rules include travel restrictions, a curfew and limits on the size of gatherings.

Vietnam also has also moved to restrict gatherings. In major metropolises like Ho Chi Minh City and Hanoi, people are allowed to leave their homes only for certain purposes, including purchasing food and medicine. On Monday, the government began restricting movement in the city of Can Tho for 14 days, Reuters reported.

The country had been a model of virus containment until May, when a spike in infections began. A third of the 30,000-plus cases Vietnam has logged since the start of the pandemic came over the past week.

Malaysia, too, has reported more than 57,000 new cases from July 4 to July 11. Indonesia, which has logged more than 243,000 new cases over the same time period, is struggling with a shortage of oxygen supplies amid a surge in the country.

Jen Psaki, the White House press secretary, said Friday that the Biden administration is dispatching 3 million vaccine doses to Indonesia and would also otherwise increase assistance.

https://www.washingtonpost.com/world/2021/07/12/coronavirus-latest-updates/
 
Last edited:
If you're under 75 years old with less than 3 health conditions, then their is absolutely no reason to take any of these vaccines.

No reason? I'll give you 3:

1) even if you are fine, you still may kill others by spreading the disease

2) all the data points to the fact that healthy young people are far more likely to die or have serious side effects from covid then they are from the vaccines, it may be 1 in a million, but the vaccine side effects are 1 in many million. (use your maths)

3)we know a lot more about how the vaccines work than we do the disease, why would you take your chances with one and not the other?
 
No reason? I'll give you 3:

1) even if you are fine, you still may kill others by spreading the disease

2) all the data points to the fact that healthy young people are far more likely to die or have serious side effects from covid then they are from the vaccines, it may be 1 in a million, but the vaccine side effects are 1 in many million. (use your maths)

3)we know a lot more about how the vaccines work than we do the disease, why would you take your chances with one and not the other?

I can't believe you seriously replied to that post.
 
Malaysia to Phase Out China’s Sinovac Vaccine
By Sebastian Strangio | July 16, 2021

thediplomat_2021-07-16.jpg

Malaysia’s Ministry of Health said yesterday that the country will stop administering the COVID-19 vaccine produced by China’s Sinovac Biotech once its current supplies run out, amid mounting evidence that the vaccines have limited efficacy against the Delta variant that is currently ravaging Southeast Asia.

Health Minister Adham Baba told a press conference that the Malaysian government has secured about 45 million doses of the Pfizer-BioNTech vaccine, enough to cover 70 percent of its population, compared to 16 million doses of Sinovac’s shot.

“About half of the 16 million have already been distributed, so the rest will be used to cover second doses,” Adham said, according to Reuters. “For those who have yet to be vaccinated, they will receive the Pfizer vaccine.”

The announcement came as Malaysia marked its third straight day of record COVID-19 infections, as it battles a spiraling outbreak of the virus. This brought Malaysia’s total number of infections to 880,782, the worst in Southeast Asia in per capita terms, and its death toll to 6,613.

The Malaysian decision reflects increasing concerns about the efficacy of Chinese-made vaccines against the more transmissible Delta variant of COVID-19, first identified in India.

Last week, health authorities in Indonesia announced that they are considering offering a booster shot to medical workers immunized with Sinovac’s vaccine, following in the footsteps of nations like Turkey and the United Arab Emirates. Indonesia has vaccinated hundreds of thousands of healthcare workers with the Sinovac shot and thousands of them are now testing positive for COVID-19; some have even died.

Yesterday, Thailand, battling its own devastating wave of Delta cases, became the first nation to offer a booster shot of AstraZeneca vaccine to people who have already been given the Sinovac shot, after seeing a similar spike in infections among health workers who had received the vaccine.

The moves follow the mounting evidence about the relatively low efficacy of the Chinese-made vaccines. A study published last week by researchers at the University of Hong Kong found that people inoculated with the Pfizer-BioNTech vaccine had antibody levels 10 times higher than those who opted for Sinovac.

https://thediplomat.com/2021/07/malaysia-to-phase-out-chinas-sinovac-vaccine/
 
@ShinkanPo @JDragon Beijing is contemplating the red pill to have any chance of reopening their borders again, after spending months talking shit on the vastly-superior mRNA vaccines that they previously deriled as "human experiment". :eek:

This is particularly amusing since the fake news perpetuated by China (and Russia) against the "untested and dangerous" mRNA vaccines are still being regurgitated by willful-ignorant anti-vaxxers right here in the West. <Lmaoo>
----

1.4 billion doses later, China is realizing it may need mRNA COVID vaccines
BY GRADY MCGREGOR | July 16, 2021

18virus-china-vaccine-1-videoSixteenByNineJumbo1600.jpg

China is the only major economy in the world not to approve or distribute COVID-19 vaccines that use the mRNA technology proven to be one of the most effective tools in preventing the spread of COVID-19. But China’s mRNA stance may be changing.

On Thursday, Chinese media outlet Caixin reported that Chinese regulators had completed a review of the COVID-19 jab developed by German mRNA vaccine maker BioNTech and distributed locally via China’s Fosun Pharma. Fosun is still awaiting final approval from regulators, but, once approved, Fosun could deploy the 100 million doses it acquired from BioNTech last December to the Chinese market by the end of 2021.

The approval would also unlock Fosun’s capacity to produce 1 billion more BioNTech shots domestically per year, part of the deal Fosun and BioNTech struck in May to make a new joint venture company in China.

The anticipated approval is a long time coming.

Fosun has been applying to get the BioNTech vaccine approved in the Chinese market since at least last November, when BioNTech and its other global distributor Pfizer first announced clinical data showing that the mRNA vaccine was effective against COVID-19. The Pfizer and BioNTech vaccine has since gained approval from the World Health Organization and has proved to be highly effective, including against the Delta variant, in halting outbreaks and preventing deaths related to COVID-19 in real-world settings.

China’s delayed approval of the BioNTech jab is likely due, in part, to the government publicly casting doubt on the usefulness of mRNA vaccines earlier this year and the promotion of its homegrown alternatives.

But the recent rise of the COVID-19 Delta variant may be pushing Beijing to change tack. Amid Delta-driven COVID-19 outbreaks, foreign governments appear to be losing some confidence in the performance of Chinese vaccines compared with mRNA vaccines from companies like BioNTech and Moderna. And Beijing may be coming around to the idea that an mRNA vaccine could bolster its own pandemic response and ease its long-awaited border reopening.

China and mRNA

China’s resistance to mRNA technology became apparent earlier this year, when state media outlets attempted to sow doubt about mRNA jabs from companies like Pfizer as a means to promote China’s domestically produced shots.

On Jan. 15, the Global Times, a nationalistic tabloid, blasted Western media outlets for their critical coverage of Chinese jabs and hinted that relying on new mRNA vaccines was dangerous.

“This large-scale promotion of Pfizer’s vaccine is a continuous process of large-scale testing on human beings,” the Global Times wrote.

Days later, the People’s Daily, the state-owned mouthpiece of the Chinese Communist Party, followed up with a story that promoted an unproven link between deaths in Norwegian nursing homes and Pfizer’s shot.

Nicholas Thomas, a professor of health security at the City University of Hong Kong, says skepticism of Pfizer jabs has spread to the Chinese public, and “consistently negative views” toward mRNA vaccines have proliferated on China’s tightly controlled social media platforms.

“The domestic China narrative on vaccines has been exclusively tilted towards the inactivated virus types” as a means to promote the homegrown shots, says Thomas.

Instead of mRNA, China’s leading vaccine makers, namely the state-owned Sinopharm and private firm Sinovac, rely on inactivated vaccine technology. These vaccines introduce a killed—or inactivated—form of COVID-19 into the body’s immune system, and China made the bet that using the century-old approach would create fewer regulatory and production problems than newer methods.

But China’s official line regarding mRNA vaccines has softened since January.

“Everyone should consider the benefits mRNA vaccines can bring for humanity,” Gao Fu, director-general of the Chinese Center for Disease Control and Prevention, said in a speech in April.

But Gao’s comments have not marked a complete reversal in China’s stance toward mRNA vaccines, notes Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations.

“We haven’t seen any strong efforts to promote mRNA vaccines in China,” Huang says. “There is a political concern that if China approves the mRNA vaccines, it might send a signal that leads people to question the effectiveness of the existing [Chinese] vaccines.”

China may be trying to find a sort of middle ground on the issue.

Caixin reports that authorities plan to use the BioNTech jabs not as alternatives to its domestically produced shots, but instead as optional booster shots after people get a two-dose regimen of Chinese vaccines. Thomas says this measure may be the best way for China to avoid undermining confidence in its existing vaccine campaign while also improving immunity in its population.

“[BioNTech booster shots] would combine with, and thereby validate, the existing vaccine regime in China,” says Thomas.

China may also eventually add mRNA shots from domestic producers.

Walvax Biotechnology, a private vaccine maker based in China’s southwestern Yunnan province, has the leading mRNA vaccine candidate in China and is awaiting clearance to begin final Phase III trials.

“I believe China really needs to have its own mRNA vaccine,” says Dr. Tong Xin, director of research development at Walvax. “This vaccine technology has been proved effective…I really hope it gets launched on Chinese land.”

Waning Confidence

For its existing vaccines, China is largely relying on Sinopharm and Sinovac jabs, which were recently approved for emergency use by the World Health Organization.

But even with the WHO’s backing, governments globally appear to be losing confidence in the jabs as questions crop up about the efficacy of Sinovac and Sinopharm vaccines, especially against the more transmissible Delta variant.

In Thailand, authorities announced on Monday that people who got injected with one dose of Sinovac would get AstraZeneca’s jab as their second dose and fully vaccinated health workers would be offered a booster shot of Pfizer or AstraZeneca. The move came after Thailand reported 618 COVID-19 infections and one death among 677,000 medical workers who were fully vaccinated with Sinovac’s two-dose regimen.

Indonesia’s health minister also recently hinted that the country will reduce its reliance on Sinovac shots amid reports that hundreds of health care workers had contracted COVID and 10 had died of the disease after receiving Sinovac jabs.

The United Arab Emirates recommends that people receiving the Sinopharm jabs get a booster shot of Pfizer six months after they complete their Sinopharm regimen.

Ashley St. John, an immunologist at Duke-NUS Medical School in Singapore, says that all available evidence points to Sinovac and Sinopharm jabs preventing infections and saving lives, even with the rise of new variants.

Sinovac and Sinopharm have not released data on how their COVID vaccines perform against new variants. Scientific studies conducted before the emergence of the Delta variant showed that the Sinovac and Sinopharm jabs were 50% and 79% effective, respectively, in preventing COVID-19 infections. The BioNTech-Pfizer vaccine, meanwhile, was 95% effective against COVID-19 in clinical trials and is likely to be at least 64% effective against the Delta variant.

St. John says there is no reason for countries to stop using Sinovac or Sinopharm jabs, unless they have a better option.

“There will be people who survived COVID because they have [Sinovac and Sinopharm] vaccines,” she says. “But some countries have other options that they see as better…The mRNA vaccines are performing better, so it makes sense to endorse that.”

Closed Borders

China may also need to accept the mRNA shots to reopen its borders.

Relying largely on Sinovac and Sinopharm, China has distributed over 1.4 billion vaccine doses to its citizens, enough to fully cover over half its population. But even with China’s blistering vaccination pace, the country may not reopen its borders until mid-2022, in part owing to concerns that the Sinovac and Sinopharm jabs may be effective in preventing deaths, but limited in their ability to prevent transmission of the virus, the Wall Street Journal reports.

China’s borders are still locked to most outsiders, and Beijing continues to adhere to a strict COVID zero strategy to stamp out even small outbreaks. After a COVID-19 outbreak infected dozens of people in the southern city of Guangzhou in June, for example, authorities locked down large parts of the city, sent thousands of people into quarantine, and tested millions for COVID-19.

“If China still sticks to this containment-based approach [to COVID-19], that means its priorities are preventing infections. There are signs that Sinovac and Sinopharm’s inactivated vaccines are not that effective in terms of achieving that objective,” says Huang.

If China does not embrace mRNA vaccines, it may get left behind countries that do.

“What is now clear is that [mRNA] technology works and is superior to the current Chinese [inactivated] approach,” says Thomas. “The Chinese government needs to unpick its own position on mRNA vaccines if it is to provide better community protection as it opens up.”

https://fortune.com/2021/07/16/china-mrna-vaccine-pfizer-biontech-fosun-doses/amp/
 
Last edited:
@ShinkanPo @JDragon Beijing is contemplating the red pill, after spending months talking shit on the vastly-superior mRNA vaccines.<Lmaoo>

This is particularly amusing since some of the fake news made in China (and Russia) against mRNA vaccines are still being regurgitated by anti-vaxxers in the WR.
So what's the truth about China anyways?

Are tens of millions of people dying of COVID there because their vaccine is ineffective?

Nobody really believed their numbers to begin with, but if their vaccine isn't even effective, shouldn't they be experiencing a total catastrophe right now?​
 
Too bad, so sad for China. Hope their country collapses due to all the treachery and deceit. Karma is a bitch.

Now they need mRNA vaccines to reopen their borders? They can go fuck themselves.
 
No reason? I'll give you 3:

1) even if you are fine, you still may kill others by spreading the disease

The drug is not authorized for transmission reduction. It says clearly in the EUA that transmission was not part of the clinical data.

2) all the data points to the fact that healthy young people are far more likely to die or have serious side effects from covid then they are from the vaccines, it may be 1 in a million, but the vaccine side effects are 1 in many million. (use your maths)
Not scared.


3)we know a lot more about how the vaccines work than we do the disease, why would you take your chances with one and not the other?
I'm not injecting myself with the disease either.
 
So what's the truth about China anyways?

Are tens of millions of people dying of COVID there because their vaccine is ineffective?

Nobody really believed their numbers to begin with, but if their vaccine isn't even effective, shouldn't they be experiencing a total catastrophe right now?​
They regularly perform the harshest of lockdowns

If you follow China news, it’s seriously like every other week some city goes on lockdown.
 
So China is going to make their own Meritage vaccine
 
China's vaccine is based on older inactivated virus, which only gives around 70% protection from the past data we've seen from flu vaccines. There is a reason why they need to update flu vaccines every year due to the low efficacy against new variants.
 
Back
Top